December 2013 FDA Recall Drug by Qualitest Pharmaceuticals
D-394-2014 - Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.

This Class III drug recall was voluntarily initiated by Qualitest Pharmaceuticals on December 16, 2013 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-394-2014

Reason for Recall
Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.
Initiated
12-16-2013
Reported
01-08-2014
Quantity
438,055 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Qualitest Pharmaceuticals
Nationwide and Puerto Rico
Cetirizine Hydrochloride Syrup (Cetirizine Hydrochloride Oral Solution, USP) 1 mg/mL, 120 mL and 480 mL bottles, Rx only. Mfg. for: Qualitest Pharmaceuticals, Huntsville, AL 35811. NDC 0603-9063-54 (120 mL), NDC 0603-9063-58 (480 mL).

Batch or Lot Expiration Information

Lot# Lot Numbers: NDC 0603-9063-54 (120 mL): L081K12A, exp. 4/14; L082K12A, exp. 4/14; L062M12A, exp. 6/14; L063M12A, exp. 6/14; L064M12A, exp. 6/14; L054A13A, exp. 7/14; L055A13A, exp. 7/14; L057A13A, exp. 7/14; L058A13A, exp. 7/14; L075B13A, exp. 8/14; L076B13A, exp 8/14; L003C13A, exp. 8/14; L004C13A, exp. 8/14; and L005C13A, exp. 8/14 NDC 0603-9063-58 (480 mL): L081K12B, exp. 4/14; L082K12B, exp. 4/14; L059A13A, exp. 7/14; L114E13A, exp. 10/14; L026G13A, exp. 12/14; and L081J13A, exp. 3/15.